Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-08
2005-02-08
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
06852687
ABSTRACT:
The present invention relates to a method for treating a subject having a condition or disease involving apoptosis, which comprises administering an effective amount of albumin to the subject. The apoptosis inhibiting activity of albumin can be increased by administering a cell growth factor such as epidermal growth factor, transforming growth factor, fibroblast growth factor, hepatocyte growth factor, insulin-like growth factor, platelet-derived growth factor and nerve growth factor and/or vitamin A together with albumin.
REFERENCES:
patent: 5942487 (1999-08-01), Ogawa et al.
patent: 6043213 (2000-03-01), Tsubota
patent: 6087395 (2000-07-01), Watanabe et al.
patent: 20010036939 (2001-11-01), Fliss
patent: 20020007217 (2002-01-01), Jacob et al.
Zoellner et al. Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin. Microvasc. Res. Mar. 1999, 57(2): 162-73.*
Zoelnner et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. Oct. 1996; 109 ( Pt 10):2571-80.*
Jose Iglesias et al.; “Albumin Is A Major Serum Survival Factor For Renal Tubular Cells And Macrophages Through Scavenging Of ROS”; The American Physiological Society; 1999; pp. F711-F722.
Hans Zoellner et al.; “Inhibition of Mircovascular Endothelial Apoptosis In Tissue Explants By Serum Albumin”; Microvascular Research 57; 1999; pp. 162-173.
Shih-Lan Hsu et al.; “Retinoic Acid-Induced Apoptosis Is Prevented By Serum Albumin And Enhanced By Lipiodol In Human Hepatoma Hep3B Cells”; Cancer Letters 129; 1998: pp. 205-214.
Yiqun Wang et al.; “BFGF Suppresses Serum-Deprivation-Induced Apoptosis In A Human Lens Epithelial Cell Line”; Experimental Cell Research 249; 1999; pp. 123-130.
Anita Singh et al.; “Synergistic Interaction Of Growth Factors And Albumin In Regulating Estradiol Synthesis In Breast Cancer Cells”; Molecular And Cellular Endocrinology 85; 1992; pp. 165-173.
Goran Boskovic et al.; “Local Control Of α 1-Proteinase Inhibitor Levels: Regulation Of α 1-Proteinase Inhibitor In The Human Cornea By Growth Factors And Cytokines”; Biochimica et Biophysica Acta 1103; pp. 37-46.
Podskochy et al., “Apoptosis in UV-exposed Rabbit Corneas”, 2000 Lippincott Williams & Wilkins Inc., Philadelphia, pp. 99-103, Cornea 19(1), 2000.
Heiligenhaus et al., “Apoptosis in human non-necrotizing stromal herpes simplex keratitis”, Klin Monatsbl Augenheilkd 2000 Sep.; 217(3): 178-82.
Aoyama-Hayashi et al., “PGE1inhibited daunorubicin-induced apoptosis of human leukemia cell line”, Japanese Journal of Inflammation, vol. 18, No. 5 Sep. 1998, pp. 369-376.
Higuchi Akihiro
Tsubota Kazuo
Audet Maury
Sucampo AG
Sughrue & Mion, PLLC
Tate Christopher R.
Tsubota Kazuo
LandOfFree
Method for inhibiting apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461332